Phase I study of bevacizumab and temsirolimus combination therapy in advanced malignancies: safety, efficacy, and ovarian cancer expansion is a research paper published in The Oncologist (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Clinical and Translational Science
Grant: UM1TR0045906
NIH Clinical and Translational Science
Grant: 1UL1 TR003167
American Cancer Society
MeSH Terms
Keywords